LINDA ELBERT: Open Payments
NPI 1376871186 · ENCINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 43 payments from 11 companies in 2025. Trend: 2023 $963 · 2024 $849 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $336 |
| UCB, Inc. | 7 | $240 |
| Janssen Biotech, Inc. | 4 | $97 |
| Botanix SB Inc | 3 | $87 |
| REVANCE THERAPEUTICS, INC. | 4 | $79 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| Biofrontera Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
Products named: Bimzelx, SKYRIZI, BOTOX, TREMFYA, SOFDRA, DAXXIFY, RINVOQ, Zoryve.
Industry payments across CA — which companies pay providers there.
